In addition, our work group previously demonstrated in a chronic ulcerative colitis model that the NLRP3 inflammasome (canonical and non-canonical pathways) is inhibited by apigenin administration by down-regulating IL-1β and IL-18 due to regulation of cleaved caspase 1 [60]. This evidence concerns the gene NLRP3 and ulcerative colitis.